2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Mycotoxicosis: new trials by email Literature Review of Mycotoxicosis trials Research Report on Mycotoxicosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya ACCS100, Calcium carbonate placebo - Aflatoxicosis | Phase 2 | Completed | Kenya Medical Research Institute | 50 | 2014-08-01 | 2014-09-16 |
| Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100" ACCS100, Placebo - Dietary Carcinogenesis | Phase 2 | Completed | Texas Enterosorbents Incorporated | 234 | 2012-09-01 | 2016-04-19 |
| Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning Silibinin - Amatoxin Poisoning, Amanita Poisoning | Phase 2 | Terminated | Mylan Specialty, LP | 148 | 2009-11-10 | 2022-04-07 |
Aflatoxin Poisoning (2) · Liver Failure (1) · Mushroom Poisoning (1) · Neoplasms (1)
Chemically-Induced Disorders (3) · Poisoning (3) · Digestive System Diseases (1) · Foodborne Diseases (1) · Hepatic Insufficiency (1) · Liver Diseases (1)
ACCS100 (2) · Calcium Carbonate (1) · Silybin (1) · sodium calcium aluminosilicate, hydrated (1)
Kenya Medical Research Institute (1) · Mylan Specialty, LP (1) · Texas Enterosorbents Incorporated (1)
United States (2) · Kenya (1)
Bradley H Pollock, MPH, Ph.D. (1) · Ellen Yard, PhD (1) · John Vulule, PhD (1) · Johnni Daniel, MPH (1) · Samuel Amwayi, MD (1) · Timothy Philips, PhD (1) · Wallis Marsh, MD (1)